ArticleExperimental biology and medicine (Maywood, N.J.)2021

Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database.

Jeff Owsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.